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Background/aim: The aim of the study was to evaluate the effect of Ramadan fasting on 
metabolic markers, body composition and dietary intake in native Emiratis of Ajman, UAE 
with the metabolic syndrome (MS).
Design: 19 patients (14 Female, 5 Male) aged 37.1 ± 12.5 years, were encouraged healthy 
lifestyle changes during fasting and data was collected 1 week before and in the fourth week 
of Ramadan.
Results: No patients experienced complications or increased symptoms of hypoglycemia 
  during Ramadan. Total energy consumption remained similar. Meal frequency decreased 
(3.2 ± 0.5 vs 2.1 ± 0.4 meals/day). Protein intake decreased 12% (P = 0.04) but fat intake 
increased 23% (P = 0.03). Body weight (103.9 ± 29.8 vs 102.1 ± 29.0 kg, P = 0.001) and 
waist circumference (123 ± 14 vs 119 ± 17 cm, P = 0.001) decreased. Forty percent of patients 
increased their physical activity due to increased praying hours. Fasting P-glucose (6.3 ± 1.7 
vs 6.8 ± 2.0 mmol/L, P = 0.024) and B-HbA1c concentrations 6.3 ± 0.9 vs 6.5% ± 0.9%, 
P = 0.003) increased but P-insulin concentration, HOMA-IR index and lipid concentrations 
remained unchanged.
Conclusion: The present study investigated the effect of Ramadan fasting on dietary intake, 
metabolic parameters and body composition showing that the energy consumption per day did 
not decrease, although the fat intake increased. However, the patients lost weight and reduced 
their waist circumference. Ramadan fasting has also elicited small but significant increases in 
Glucose and HbA1c after 4 weeks.
Keywords: metabolic syndrome, Ramadan, fasting, body composition, type 2 diabetes, obesity, 
Ajman
Introduction
Ramadan is the holiest month in the Islamic calendar. Since it is a lunar-based month 
its duration varies between 29 and 30 days. Muslims fast everyday from dawn to sunset 
and refrain from drinking and eating for this period; however, there are no restrictions 
on food or fluid intake between sunset and dawn. The period of fast may vary depending 
on the geographical location of the country and the season of the year.1
The Ramadan model of fasting is abundantly available but not extensively studied 
and the physiological changes induced by Ramadan fasting are not well known. 
Although there have been reports on the metabolic changes during and after Ramadan 
in healthy subjects2,3 and in patients with diabetes4,5 the results have been conflicting.6,7 
The variability in the results is probably attributed to several confounding variables 
like ethnicity, hours of fasting, climatic conditions, cultural influences, physical 
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activity and most commonly the dietary patterns.6 Muslims 
with diabetes and other chronic diseases are exempted from 
fasting, when fasting may lead to harmful consequences. 
However, many patients insist on participating in   Ramadan 
fasting. Because of the conflicting results regarding the 
effects of Ramadan fasting, physicians working in Muslim 
communities often face a difficult task when advising patients 
with diabetes or Metabolic Syndrome (MS) whether it is 
safe to fast, as well as recommending the proper dietary   
and drug regimens.
Food consumption patterns and dietary habits in the 
  Arabian Gulf have changed in the recent past, due to 
increasing wealth and westernization.8 Obesity and type 2 dia-
betes mellitus (DM) have recently reached epidemic propor-
tions in the region. The prevalence of the MS in the United 
Arab Emirates (UAE) is now reported to be one of the highest 
in the world reaching approximately 40% using the National 
Cholesterol Education Program (NCEP) definition or the 
International Diabetes Federation (IDF) definition.9
The high prevalence is possibly caused by genetic   factors 
in combination with rapid socioeconomic developments. 
Many Emiratis have in the past 20–30 years adapted a 
sedentary lifestyle with a minimum of physical activity and 
an over consumption of energy-dense food.10 Presence of 
MS serves well as a simple clinical tool for identifying high-
risk subjects predisposed to cardiovascular disease.11 The 
dominant underlying risk factors for this syndrome appear 
to be abdominal obesity and insulin resistance. Prevention 
or reduction of obesity, particularly abdominal obesity, is a 
main therapeutic goal in patients with MS.12
Weight reduction can be optimally achieved with a 
  multimodality approach by adapting to healthy lifestyle 
through diet modification, physical activity and   possible 
pharmacological therapy.13 A moderate weight loss of 
about 5% has shown to improve glycemic and blood 
pressure   control, improve insulin action, decrease fasting 
plasma glucose concentrations, as well as improve lipid 
concentrations.14
Based on the Ministry of Economy census in 2005, 
76% of the total population is Muslim in the UAE,15 and 
most of the adult population adheres to the Ramadan   
fasting.
To the best of our knowledge, we are not aware of any 
previous published reports on the effect of Ramadan fast-
ing on the subjects with the MS in this region. Therefore, 
the present pilot study was undertaken at Rashid Centre for 
Diabetes and Research (RCDR), Ajman, UAE to evaluate the 
effect of Ramadan fasting on the metabolic markers, body 
  composition and dietary intake in the subjects with MS in 
Ajman, UAE.
Materials and methods
Subjects
The subjects were randomly selected based on the inclusion-
exclusion criteria. Twenty-three subjects were recruited, four 
withdrew and 19 subjects (14 female and five male) aged 
37.1 ± 12.5 years completed the study.
The inclusion criteria included UAE national   (passport 
holder) and abiding to Ramadan fast with the MS. 
A   participant was defined as having MS if three or more 
of the following criteria were met, according to the IDF 
recommendations:16 (1) Central obesity, ie, waist circumfer-
ence $94 cm for men and $80 cm for women (criteria for 
Middle East (Arab) population); (2) Hypertriglyceridemia 
$150 mg/dL (1.7 mmol/L); (3) Low HDL-cholesterol 
(HDL-C), ie, ,40 mg/dL (1.03 mmol/L) in males and 
,50 mg/dL (1.29 mmol/L) in females; (4) Raised blood 
  pressure: $130/85 mmHg; (5) Raised fasting plasma glucose 
(FPG): $100 mg/dL (5.6 mmol/L).
Exclusion criteria included Type 1 diabetes, Type 2 
  diabetes for more than 5 years, Type 2 diabetes on insulin 
treatment, HbA1c . 10% (National Glycohemoglobin Stan-
dardization Program (NGSP) standard), history of repeated 
hypoglycemic episodes, pregnancy or acute and chronic 
diseases.
The study protocol was approved by the regional Ethical 
committee of Ministry of health, UAE and the purpose of 
the research was explained to the participants and written 
consent was obtained. The patients stated that they had not 
changed any medication in the last 3 months or suffered 
with any acute disease or infection in the preceding 2 weeks 
prior to the study.
All the subjects were advised to recognize warning 
symptoms of dehydration, hypoglycemia and other possible 
complications and were encouraged healthy lifestyle changes 
during Ramadan fasting.
The data was collected via structured interview supported 
by a questionnaire; the objective of the interview was to 
gather socio-demographic data, current treatment, lifestyle 
changes during fasting, days of fasting, sleeping hours, 
frequency of hypoglycemia and compliance to the dietary   
instructions.
Data collected included (1)   sociodemographic data, 
diabetes type, duration of the   disease, complications, and 
comorbidities; (2) current treatment, frequency, and type 
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glycemia); (3) physical activity, food/fluid intake, sleep 
patterns, and body weight; and (4) consequences of the 
Ramadan period with regards to change in lifestyle, change 
in treatment, and change in frequency of hypo/hyperglycemia 
episodes. The methodology of the study and recommendations 
on how to conduct the interviews and complete the 
questionnaires were presented to each investigator during 
briefing meetings by representatives of the study. An identical 
questionnaire was translated into the local language.
The data was collected 1 week before Ramadan (RA1) 
and in fourth week of Ramadan (29th and 30th of Ramadan) 
(RA2). The climate in the region during Ramadan was hot and 
dry and the average minimum and maximum temperature was 
29.7°C and 44.7°C respectively throughout the month.
Anthropometric measurements
The body weight and height were measured by the same person 
using an electronic balance with stadiometer (SECA-Germany, 
capacity: max 250 kg, range: 110 cm/43 ins, 200 cm/79 ins) 
and recorded to the nearest 0.1 kg and 0.1 cm respectively. The 
body composition was determined by bioelectric impedance 
using InBody-230 (Biospace, Dogok-dong, South Korea) to 
study the fat mass (FM), muscle mass (MM) and total body 
water (TBW). The analysis was   performed each time under 
standardized conditions ie, 2 hours fasting and no intense 
physical exercise 12 hours prior to the test and in fourth week 
of Ramadan before midday, no menstrual cycle and ±2 days. 
The body mass index (BMI) (calculated as weight (kg)/height2 
(m2)) was also estimated.
Basal metabolic rate (BMR) indicates the minimum 
energy requirements needed to sustain vital functions while 
at rest. The InBody230 makes it possible to estimate BMR 
using a known regression equation based on Fat Free Mass 
(FFM), a generalized prediction equation is proposed as 
BMR = 370 + 21.6 (FFM).17
The waist circumference (WC) was defined as the 
abdominal circumference immediately above the iliac crest 
and the hip circumference was measured in a horizontal 
plane at the level of the maximal extension of the buttocks 
according to the National Health and Nutrition Examination 
Survey (NHANES) guidelines.18
Systolic and diastolic blood pressure was measured in 
the right arms and in the sitting position of the subjects who 
had been resting for at least 10 min.
Dietary intake
The dietary compliance was measured using a visual analog 
scale19 and the nutrient intake was evaluated by means of 
a 3 day food record. The patients were instructed on how 
to record their daily dietary intake for 3 consecutive days; 
two weekdays and one weekend day.20 Food quantities were 
explained using household measurements (plates, glass, slice, 
cups, spoons, etc) and a sample food record was given for 
easy understanding. Then individual records were reviewed, 
and the nutrient calculations were carried out using the 
USDA’s food composition table.21
Biochemical assays
The blood samples were collected after 8–10 hours of fasting, 
and processed for fasting plasma glucose using (Enzymatic 
Hexokinase method), B-HbA1c using (Turbidimetric Inhibition 
Immunoassay TINIA), plasma Insulin and C-peptide using 
(electrochemiluminescence Sandwich Assay). Plasma lipids 
(Cholesterol and Triglyceride, HDL and LDL-Cholesterol) 
were analyzed using enzymatic methods. The plasma apolipo-
proteins were analysed using immunoturbidimetric assay.
Liver function tests including ALP using (standardized 
method), AST using (rate assay without pyrodoxial   phosphate 
activation method), ALT using (Colorimetric without pyro-
doxial phosphate activation method), GGT using (enzymatic 
colorimetric method).
Plasma creatinine was analyzed using (kinetic colorimetric 
Jaffes method and enzymatic colorimetric method), Urea 
using (kinetic colorimetric assay), and CRP using (enhanced 
immunoturbidimetric assay).
All the above mention tests were performed in a Roche 
COBAS 6000 analyzer.22
We used a homeostasis model assessment for insulin 
resistance (HOMA-IR). The formula used to calculate 
HOMA-IR was23 = (glucose (mmol/l) × insulin)/22.5.
Statistical analysis
The analyses were performed with STATISTICA (version 8, 
StatSoft®, Tulsa, USA).
The results are reported as mean values and standard 
deviations, group means before and after Ramadan was 
compared using Wilcoxon matched pair test. A P-value of 
less than 0.05 was considered as statistically significant.
Results
Fasting and meal frequency
The average number of fasting days was 26.2 (range 23–29; 
SD 2.0) and the average hours of fasting were 14 hours and 
20 ± 10 minutes. Since Islamic rules do not permit females to 
fast during the menstrual period, all the females in the study 
missed 4 ± 2 days of fasting. As the subjects were fasting Diabetes, Metabolic Syndrome and Obesity:   Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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from sunrise to sunset the meal frequency decreased from 
3.2 ± 0.5 to 2.1 ± 0.4.
Medication
Eight subjects were on metformin as monotherapy for 
  glucose lowering therapy. Three type 2 diabetes and 
two obese   subjects were on antilipemic drugs (statins); and 
two other type 2 diabetes patients were on antihypertensive 
drugs   (calcium-channel blockers). The frequency of taking 
medicines was enquired in the questionnaire to learn that 
n = 9 (64%) patients were taking their medications everyday 
whereas n = 2 (14%) of the subjects often missed their 
medication during the fasting month.
Metabolic complications  
and hypoglycemia
No patients experienced severe hypo or hyperglycemia or 
any other acute metabolic complication during Ramadan 
but two patients had slight symptoms of hypoglycemia 
twice in the month of fasting. This frequency or severity of 
hypoglycemic event was similar to the non-fasting months. 
The total sleeping time remained comparable before and dur-
ing Ramadan (8.8 ± 0.8 vs 8.4 ± 0.6 hours/day). However, 
during Ramadan there was delayed and shortened periods 
of sleep in the night, which is compensated by day time   
sleeping.
Physical activity
Seven subjects (37%) reported to have reduced their physical 
activity during the month and four (21%) subjects maintained 
the same physical activity; however eight (42%) of them 
reported to have increased their activity due to the extended 
hours of praying after the sunset.
Anthropometric measurements
After 1 month of fasting (RA2), body weight, BMI and the 
WC decreased significantly compared to before Ramadan 
(RA1) (Table 1). This weight loss was reflected in the body 
composition, by a reduced FM, TBW and MM. However, 
this decrease was not significantly from any one compo-
nent of the body composition. The systolic (129 ± 19 vs 
126 ± 12 mmHg) and diastolic blood pressure (69 ± 10 vs 
70 ± 11 mmHg) showed no significant changes during the 
month of fasting.
Dietary intake
Eight (42%), seven (37%) and four (21%) subjects reported 
poor, average and good dietary compliance respectively. 
Mean daily energy and macronutrient intake of the   subjects 
before (RA1) and during (RA2) Ramadan fasting are 
shown in Table 2. The total energy consumption per day 
did not change during Ramadan when compared to before 
Ramadan.
During Ramadan there was a decrease in the protein 
intake and an increase in fat intake. There was a nonsignifi-
cant trend towards reduced carbohydrate intake.
Table 2 shows the distribution of calories into different 
food groups before (RA1) and during (RA2) Ramadan 
fasting. The intake of different food groups is represented 
in Table 3.
Biochemical parameters
Table 4 shows the results of plasma biochemical variables 
before (RA1) and during (RA2) Ramadan fasting.
Table 1 Anthropometric parameters 1 week before ramadan 
(rA1) and in fourth week of ramadan (rA2)
Parameter Mean (SD)
RA1 RA2
Weight (kg) 103.9 (29.8) 102.1 (29.0)*
BMi (kg/m2) 40.2 (10.2) 40.0 (10.5)**
Wc (cm) 123 (14.0) 119 (17.0)*
Whr 0.98 (0.10) 0.95 (0.11)
Fat mass (kg) 50.3 (19.6) 49.5 (20.3)
Fat % 47.3 (8.3) 46.9 (8.2)
TBW (kg) 39.5 (9.6) 38.7 (7.9)
TBW (%) 38.8 (5.8) 39.0 (5.8)
Fat free mass (kg) 53.5 (13.0) 52.6 (10.6)
Fat free mass (%) 52.7 (8.3) 53.1 (8.2)
Muscle mass (kg) 14.1 (3.5) 13.9 (2.7)
Muscle mass (%) 13.9 (2.5) 14.1 (2.4)
BMr (kcal) 1,500 (300) 1,400 (400)
Notes: Data are expressed as mean (standard deviation). *P , 0.01; **P , 0.05.
Abbreviations: BMi, body mass index; Wc, waist circumference; Whr, waist- 
to-hip ratio; TBW, total body water; BMr, basal metabolic rate.
Table 2 energy and Macronutrient intake of patients 1 week 
before ramadan (rA1) and in fourth week of ramadan (rA2)
Nutrient Mean (SD) Dietary  
recommendation  
(ADA)
RA1 RA2
Total calorie (kcal) 2,240 (700) 2,300 (600) 2000 kcal
carbohydrate (g) 264 (94) 249 (65)
carbohydrate (%) 46.4 (5.5) 43.5 (4.9) 45%–65%
Protein (g) 78.0 (24.7) 68.7 (23.9)*
Protein (%) 14.4 (3.0) 12.0 (2.3)* 15%–20%
Fat (g) 85.0 (28.3) 104.0 (31.8)*
Fat (%) 34.6 (4.8) 40.5 (5.5)* ,25%
Notes: ADA = American Diabetes Association, 2004 recommendations (34, 35).   
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We found an increase in fasting plasma glucose and 
HbA1c levels but these changes were not paralleled by any 
significant changes in markers for insulin resistance such 
as fasting plasma insulin and HOMA-IR index. Lipids, 
apolipoproteins, and CRP concentrations as well as kidney 
function tests such as plasma creatinine and urea concentra-
tions remained unchanged. Liver function tests such as AST, 
ALT and ALP were unchanged during the study but GGt 
decreased slightly (P = 0.02).
Discussion
We wanted to study the impact of Ramadan fasting on food 
intake, metabolic parameters and anthropometry in native 
  Emiratis in Ajman, UAE since we have found none or very 
limited previous information available from this region investi-
gating the effect of Ramadan fasting in patients with the MS.
Strict compliance to healthy dietary modifications is a 
cornerstone in diabetes and obesity management. During 
Ramadan, the meal pattern and fluid intake is markedly 
altered and there are delayed and shortened periods of sleep. 
It would be possible that these changes in meal and sleeping 
rhythm could lead to an undesirable change in metabolism. 
We found a slight but significant increase in fasting plasma 
glucose and HbA1c levels during Ramadan compared with 
before fasting. It is possible that the changes in sleep schedule 
and habits during Ramadan induce changes in the rhythmic 
pattern of a number of hormonal variables including cortisol 
which has an unfavorable influence on the glucose tolerance. 
It has also been argued that a given nutrient ingested at an 
unusual time can induce different metabolic effects.24 Previ-
ous research has shown that, unlike in non-fasting periods, 
cortisol   concentrations are biphasic during Ramadan fasting. 
These researchers reported an increase in serum cortisol start-
ing at 1200 h that reached a plateau between 1600 and 2000.25 
The altered sleep-wakefulness cycle could possibly also lead 
to changes in levels of the appetite regulating hormones lep-
tin, neuropeptide-Y and insulin that play important roles in 
the long-term regulation of energy intake and expenditure.26 
Unfortunately data on these hormones were not available in 
the current study.
Interestingly, the increased glucose and HbA1c levels were 
not paralleled by an increased insulin resistance   measured by 
HOMA IR or fasting insulin concentrations. Neither did we 
observe any differences in lipids, apolipoproteins nor in CRP 
levels before compared to during the fasting period.
During Ramadan there was a change in feeding pattern in 
which larger meals compensated for lower frequency of food 
ingestion. Therefore total energy intake during Ramadan did 
not differ compared with prior to the initiation of Ramadan. 
These findings negate the common belief that Muslims tend 
to overcompensate in terms of food intake during this fasting 
month. Similar results were reported earlier in UAE subjects27 
Table 3 Dietary intake of different food groups in patients 1 
week before ramadan (rA1) and in fourth week of ramadan 
(rA2)
Food Group  
serving
No of servings  
mean (SD)
% of total  
calorie
RA1 RA2 RA1 RA2
cereals 10.1 (4.4) 9.1 (3.7) 36.1 31.7
Legumes 0.2 (0.4) 0.1 (0.3) 0.4 0.2
Fruits 3.4 (2.1) 2.2 (1.5) 7.2 5.4
Vegetables (raw) 0.8 (0.8) 0.4 (0.5) 0.8 0.4
Vegetables  
(cooked)
0.6 (0.5) 1.1 (0.7)* 0.6 1.1
Low fat milk 0.5 (0.6) 0.2 (0.3) 1.4 0.6
Whole milk 2.4 (1.9) 1.6 (0.9) 16.1 10.4
Lean meat 3.9 (2.7) 2.9 (2.2) 7.0 5.4
Medium fat meat 1.5 (1.8) 1.6 (2.9) 4.0 4.0
high fat meat 0.0 (0.0) 0.8 (1.8) 0.0 2.8
Fat 10.3 (3.6) 14.2 (4.4)* 20.6 27.7
nuts 0.2 (0.4) 0.9 (1.4) 0.2 1.3
Sugar 6.7 (5.2) 10.5 (8.1) 5.6 9.1
Note: *P, 0.01.
Table 4 Biochemical parameters based on fasting blood samples 
in patients 1 week before ramadan (rA1) and in fourth week of 
ramadan (rA2)
Biochemical parameter Mean (SD)
RA1 RA2
P-glucose (mmol/L) 6.3 (1.7) 6.8 (2.0)**
B-hbA1c % 6.3 (0.9) 6.5 (0.9)*
P-insulin (iU/mL) 27.8 (16.7) 26.5 (19.1)
hOMA ir 7.8 (5.0) 8.1 (5.9)
P-cholesterol (mmol/L) 4.6 (1.0) 4.5 (1.0)
P-triglycerides (mmol/L) 1.65 (0.99) 1.45 (0.68)
P-hDL-cholesterol (mmol/L) 1.15 (0.21) 1.16 (0.29)
P-LDL-cholesterol (mmol/L) 2.67 (0.76) 2.57 (0.83)
P-crP (mg/L) 10.6 (9.8) 10.1 (14.2)
P-Apo-A1 (g/L) 1.32 (0.21) 1.30 (0.25)
P-Apo-B (g/L) 0.79 (0.19) 0.74 (0.21)
APOB/APOA ratio 0.61 (0.17) 0.59 (0.18)
P-AST (iU/L) 21.1 (6.6) 19.0 (5.5)
P-ALT (iU/L) 30.5 (17.4) 27.2 (15.4)
P-ALP (iU/L) 78.4 (21.5) 78.5 (21.9)
P-ggt (iU/L) 25.2 (12.1) 20.9 (9.6)**
P-creatinine (mmol/L) 57.5 (15.1) 59.0 (15.4)
P-urea mmol/L 3.73 (0.97) 3.82 (1.10)
Notes: *P , 0.01; **P , 0.05.
Abbreviations:  hbA1c,  glycosylated  haemoglobin;  hOMA,  homeostatic 
model  assessment  of  insulin  resistance;  crP,  c  reactive  protein; AST,  aspartate 
aminotransferase;  ALT,  Alanine  transaminase;  ALP,  Alkaline  phosphatase;  ggt, 
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while contradictory results were reported in Algerian and 
Indian Muslims.3,28 These discrepancies can probably be 
explained by the unique food habits in different countries.
Despite insignificant changes in the total energy intake, 
we detected a significant reduction in total weight, BMI 
and WC after 4 weeks of fasting. Similar results have 
been reported in normal subjects in Jordan25 while other 
studies have attributed the weight loss during Ramadan to 
lower calorie intake;1,2,27 however, these studies have not 
reported the changes in the body composition on weight   
loss.
We observed an insignificant trend in the body compo-
sition changes contributing to the weight loss in our study. 
It was reported that the weight loss was contributed largely 
from fat (kg) followed by TBW (kg) and to a lesser extent 
from muscle mass. It is possible that the weight loss, in part, 
could be attributed to efficient utilization of body fat during 
fasting2 and largely from the abdominal fat since also the 
waist circumference was reduced significantly.
Shariatpanahi et al1 and Saleh et al29 reported similar 
reduction in waist circumference during Ramadan fasting 
among   subjects with MS and healthy volunteers respectively. 
A reduced waist circumference usually correlates with 
improved   insulin sensitivity,30 which we could not show in 
the   present study. However, the number of participants in 
the study was limited and insulin resistance was measured 
by indirect methods (fasting insulin and HOMA IR) which 
could have influenced the result through reduced precision 
and statistic power. Liver function tests such as ALT and 
especially GGt have been shown to be biomarkers correlating 
with insulin resistance31 and central body fat.32
In  the  current  study  we  observed  a  significant 
decrease in GGt and a nonsignificant trend towards 
lower AST and ALT levels during fasting which interest-
ingly paralleled the decreased abdominal obesity in the   
patients.
Although the total energy intake was not altered 
  significantly, the selection of food certainly changed in 
the month of Ramadan. In the UAE culture special   festival 
foods that are richer in fats and sugars like thareed, harees, 
luqaimaat, sugary drinks (Vimto) are consumed in the 
fasting month.
On comparing the macronutrient consumption before and 
during Ramadan, we observed an increase in fat and decrease 
in protein intake, whereas the total carbohydrate remained 
comparable. However, the source of carbohydrate had shifted 
from complex carbohydrate (cereal, legume, fruit, vegetable) 
to more of simple sugars (sweets and sweetened drinks).
The observed increase in fat intake during Ramadan 
was in agreement to studies reported in other regions as 
well.2–4,27 We also noted a small but significant decrease in 
protein intake (2.4%), in contrast to what was reported in 
other studies.2,27
The consumption of carbohydrate and protein remained 
lower to the American Diabetic Association (ADA) recom-
mendation, while the fat intake was higher33 (Table 2).
The increased intake of dietary fat during Ramadan 
exceeded the dietary recommendations and conventional 
therapy values for treating obesity (25%–30%).34 Similar 
results have been reported in other studies in UAE, Tunisia, 
and Algeria.2,27,35
The intake of vegetables was far less (1.4–1.5 servings/day) 
than the ADA recommendations (4–5 servings/day);   however, 
the intake of cooked vegetable was increased compared to 
Pre-Ramadan due to a traditional dish called thareed, which 
consisted of vegetables like zucchini, carrot, tomato and 
cauliflower.
The intake of whole fruit was reduced; however, the fruit 
intake (two servings per day) was largely contributed only 
by dates and fruit juice during Ramadan. The subjects also 
reduced the consumption of milk and milk products, and the 
lean meat options were replaced by medium fat and high fat 
meat preparations.
Although the intake of fat and simple sugars increased 
there was no impairment in plasma lipid profile. These 
results are in line with the study reported in normal UAE and 
Kuwaiti subjects.27,29 However, the varied effect of different 
fatty acids on the lipid components is well established,36 and 
the present study did not measure the intake of saturated, 
monounsaturated and polyunsaturated fatty acids during 
the fasting month.
Summers in Ajman are extremely hot and the extreme heat 
and humidity during the study made it very difficult to spend 
time outdoors for the patients exercising. Interview results sug-
gested that physical activity was considered as moderate and 
was restricted to housework and walking; however, additional 
physical activity was induced due to “Taraouih” prayers which 
involve long periods of standing 1.5–2 hours after breaking the 
fast. These findings are in accordance to the EPIDIAR study 
which was a population based study in 13 countries.5 The 
improvement in the body compositions has been reported dur-
ing the Ramadan fasting attributed to the ‘Taraouih’ prayers.37 
We cannot rule out that this increased physical activity could 
in part have affected body weight and metabolism.
A limitation of the study was to find a control group, as 
it was not possible to find Emiratis with MS who did not fast Diabetes, Metabolic Syndrome and Obesity:  Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
415
effect of ramadan fasting
during Ramadan. Our sample size of 19 was inadequate for 
subset analyses of the differential effects of   Ramadan on gen-
der, age group, ethnicity and other population differences.
Conclusion
To the best of our knowledge, this is the first study that has 
examined the effects of fasting during Ramadan in Ajman, 
UAE, in patients with the MS. Energy intake did not dif-
fer from that reported prior to the initiation of Ramadan. 
Larger meals compensated for lower frequency of food 
ingestion during the intervals between fasting. A significant 
increase in fat intake and substantial inclusion of sweets in 
daily eating was reflected in raised glucose and HbA1c lev-
els but not evident in the lipid profile which did not change 
for the worse. Total body mass and waist circumference 
were reduced after Ramadan fasting. In some patients, the 
physical activity increased as a result of increased length of   
prayers.
As a dietary recommendation it could be advised to 
increase the vegetable and whole fruit consumption and limit 
fat and sweetened foods to improve the health benefits of 
Ramadan fasting. An additional 20–30 minutes of physical 
activity could improve the benefits of fasting on health.
Acknowledgments
Professor Lars Brudin, Kalmar, Sweden for assistance with 
statistical analyses. Cooperation of the patients selected for 
the study is thankfully acknowledged too.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Shariatpanahi ZV , Shariatpanahi MV , Shahbazi S, Hossaini A, Abadi A. 
Effect of Ramadan fasting on some indices of insulin resistance and 
components of the metabolic syndrome in healthy male adults. British 
Journal of Nutrition. 2008;100(1):147–151.
2.  El Ati J, Beji C, Danguir J. Increased fat oxidation during Ramadan fasting 
in healthy women: an adaptive mechanism for body weight maintenance. 
Am J Clin Nutr. 1995;62:302–307.
3.  Frost G, Pirani S. Meal frequency and nutritional intake during Ramadan: 
a pilot study. Hum Nutr Appl Nutr. l987;4iA:47–50.
4.  Khaled BM, Belbraouet S. Ramadan Fasting Diet Entailed a Lipid 
Metabolic Disorder among Type 2 Diabetic Obese Women. American 
Journal of Applied Sciences. 2009;6(3):471–477.
5.  Salti I, Bιnard E, Detournay B, Bianchi-Biscay M, Le Brigand C, 
Voinet C, et al. A population-based study of diabetes and its character-
istics during the fasting month of Ramadan in 13 countries: Results of 
the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. 
Diabetes Care. 2004;27:2306–2311.
6.  Benaji B, Mounib N, Roky R, et al. Diabetes and Ramadan. Review of the 
literature. Diabetes Research and Clinical Practice. 2006;73: 117–125.
7.  Trepanowski JF, Bloomer RJ. The impact of religious fasting on human 
health. Nutrition Journal. 2010;9:57:2–9.
  8.  Musaiger AO, Miladi SS, eds. Food Consumption Patterns and Dietary 
Habits in the Arab Countries of the Gulf. Cairo: FNE/RNE; 1995.
  9.  Malik M, Razig SA. The prevalence of the metabolic syndrome 
among the multiethnic population of the United Arab Emirates:   
a report of a national survey. Metab Syndr Relat Disord. Sep 2008;6(3): 
177–186.
  10.  Sierra-Johnson, et al. Eating Meals Irregularly. A Novel Environmental 
Risk Factor for the Metabolic Syndrome. Obesity. 2008;16(6):1302.
  11.  Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic 
syndrome vs framingham risk score for prediction of coronary heart 
disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005; 
165:2644–2650.
  12.  Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating 
pandemics of obesity and sedentary lifestyle. A call to action of 
clinicians. Arch Intern Med. 2004;164:249–258.
  13.  Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style 
diet on endothelial dysfunction and markers of vascular inflammation 
in the metabolic syndrome: a randomized trial. JAMA. 2004;292: 
1440–1446.
  14.  Klein, S, Sheard NF, Pi-Sunyer X, et al. Weight management through 
lifestyle modification in the prevention and management of type 2 
  Diabetes: Rationale and strategies. A statement of the American diabetes 
association, the north American association for the study of obesity and 
the American Society for Clinical Nutrition. Diabetes Care. 2004;27: 
2067–2073.
 15.  Bureau of Democracy, Human Rights, and Labor. United Arab Emirates 
international religious freedom report 2010 [report on the Internet]. 2010 
[updated November 17, 2010; cited January 12, 2011]. Available from: 
http://www.state.gov/g/drl/rls/irf/2010/148850.htm. Accessed October 
17, 2011.
  16.  http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. (retrieved 
January 5, 2011).
  17.  Cunningham JJ. Body composition as a determinant of energy expen-
diture: a synthetic review and a proposed general prediction equation. 
Am J Clin Nutr. 1991;54(6):9639.
  18.  National Health and Nutrition Examination Survey (NHANES) Anthro-
pometry Procedures Manual, Jan 2007. http://www.cdc.gov/nchs/data/
nhanes/nhanes_07_08/manual_an.pdf. (retrieved April 5, 2011).
  19.  Stubbs RJ, Hughes DA, Johnstone AM, et al. The use of visual analogue 
scales to assess motivation to eat in human subjects: a review of their 
reliability and validity with an evaluation of new hand-held computer-
ized systems for temporal tracking of appetite ratings. Br J Nutr. 2000; 
84:405–415.
  20.  The fifth international conference on dietary assessment methods 
expanding the horizon: dietary assessment in a multicultural world. 
January 26–29, 2003 Chiang Rai, Thailand. http://www.icdam.org/
Abtract_ICDAM5.pdf. (retrieved June 15, 2011).
 21.  USDA National Nutrient Database for Standard Reference, www.nal.
usda.gov/fnic/foodcomp/Data/HG72/hg72_2002.pdf. (retrieved April 5, 
2011).
  22.  Cobas 6000 analyzer series. Operator’s Manual, version 4.0.2009, 
Germany.
  23.  Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA 
  modeling. Diabetes Care. 2004;27(6):1487–1495.
  24.  Nelson W, Cadotte L, Halberg F. Circardian timings of single daily 
meal affects survival of mice. Proc Soc Exp Biol Med. 1973;144: 
766–769.
  25.  Bogdan A, Bouchared B, Touitou Y. Ramadan fasting alters endocrine 
and neuroendocrine cicardian patterns. Meal-time as a synchronizer in 
humans? Life Sci. 2001;68:1607–1615.
  26.  Kassab S, Abdul-Ghaffar T, Nagalla DS, Sachdev U, Nayar U. 
  Interactions between leptin, neuropeptide-Y and insulin with chronic 
diurnal fasting during Ramadan. Ann Saudi Med. 2004;24:345–349.
  27.  Wissam HI, Hosam MH, Amjad HJ, Samer AAB. Effect of   Ramadan 
fasting on markers of oxidative stress and serum biochemical mark-
ers of cellular damage in healthy subjects. Ann Nutr Metab. 2008;53: 
175–181.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 
an international, peer-reviewed open-access journal committed to 
the rapid publication of the latest laboratory and clinical findings 
in the fields of diabetes, metabolic syndrome and obesity research.   
Original research, review, case reports, hypothesis formation, expert 
opinion and commentaries are all considered for publication. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
Diabetes, Metabolic Syndrome and Obesity:   Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
416
Sadiya et al
  28.  Lamri-Senhadji M Y, El Kebir B, Belleville J, Bouchenak M. Assessment 
of dietary consumption and time-course of changes in serum lipids and 
lipoproteins before, during and after Ramadan in young Algerian adults. 
Singapore Med J. 2009;50(3):288–294.
  29.  Saleh SA, Elsharouni SA, Cherian B, Mourou. Effects of Ramadan 
fasting on waist circumference, blood pressure, lipid profile, and blood 
sugar on a sample of healthy. Kuwaiti Men and Women. Mal J Nutr. 
2005;11(2):143–150.
  30.  Richelsen B, Pedersen SB. Associations between different anthro-
pometric measurements of fatness and metabolic risk parameters in 
non-obese, healthy, middle-aged men. Int J Obes Relat Metab Disord. 
1995;19L:169–174.
  31.  Bonnet F, Ducluzeau PH, Gastaldelli A, et al; RISC Study Group. Liver 
enzymes are associated with hepatic insulin resistance, insulin secre-
tion, and glucagon concentration in healthy men and women. Diabetes.   
Jun 2011;60(6):1660–1667.
  32.  Wallace TM, Utzschneider KM, Tong J, et al. Relationship of liver 
enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care. 
Oct 2007;30(10):2673–2678.
  33.  American Diabetes Association. Standards of Medical Care in 
  Diabetes – 2008. Diabetes Care. 2008;31:5–11.
  34.  Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, 
et al. Evidence based nutrition principles and recommendations for 
the treatment and prevention of diabetes and related complications 
(Technical Review). Diabetes Care. 2002;25:148–198.
  35.  Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric 
parameters and food consumption in 276 type 2 diabetic obese women. 
Int J Diabetes Dev Ctries. Apr 2009;29(2):62–68.
  36.  Gardner CD, Kraemer HC. Monounsaturated Versus Polyunsaturated 
Dietary Fat and Serum Lipids: A Meta-analysis.   Arteriosclerosis, 
Thrombosis, and Vascular Biology. 1995;15: 1917–1927.
  37.  Mohktar MS, Ibrahim F. Assessment of Salat Taraweeh and Fasting 
Effect on Body Composition. 4th Kuala Lumpur International Confer-
ence on Biomedical Engineering 2008 IFMBE Proceedings, 2008;21 
Part 3, Part 4:133–136.